Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2011-12-01 FUERST THOMAS RICHARD EVP, Chief Scientific Officer Grant or award · Stock Options (right to buy) +75,000 75,000
2011-12-01 FUERST THOMAS RICHARD EVP, Chief Scientific Officer Grant or award · Stock Options (right to buy) +29,545 29,545
2011-11-22 FUERST THOMAS RICHARD SVP, Chief Scientific Officer Purchase +5,000 $1.27 $6K 15,000
2011-11-10 FUERST THOMAS RICHARD EVP, Chief Scientific Officer Purchase +10,000 $1.51 $15K 10,000
2010-12-08 FUERST THOMAS RICHARD Chief Scientific Officer Grant or award · Stock Options (right to buy) +75,000 75,000
2010-05-06 FUERST THOMAS RICHARD SVP, Chief Scientific Officer Grant or award · Stock Option (right to buy) +20,000 20,000
2010-04-05 FUERST THOMAS RICHARD Chief Scientific Officer Grant or award · Stock Option (right to buy) +350,000 350,000

Page 1 of 1 · 7 trades